Name
bp2b_am
Label
AM Diastolic Blood Presure 2nd Measurement
Units
millimeters of mercury
Type
numeric
Tags
HL
Visit (Number) vs AM Diastolic Blood Presure 2nd Measurement
N Mean StdDev Median Min Max Unknown Total
Baseline (BL) - - - - - - 1,516 1,516
Clinical Evaluation (CE) 1,504 73.4 ± 21.1 78.0 -2.0 138.0 12 1,516
Diagnostic Visit (DX) 1,232 77.6 ± 13.9 78.0 -3.0 120.0 284 1,516
CPAP Titration Visit (CPAP) 1,056 75.2 ± 18.6 78.0 -3.0 130.0 460 1,516
Two Month Post-CPAP Neurocognitive Visit (2M) 879 76.3 ± 12.7 78.0 -2.0 122.0 637 1,516
Four Month Post-CPAP Neurocognitive Visit (4M) 833 63.3 ± 30.2 74.0 -2.0 110.0 683 1,516
Six Month Post-CPAP Neurocognitive Visit (6M) 851 76.5 ± 12.5 78.0 -2.0 118.0 665 1,516
Gender vs AM Diastolic Blood Presure 2nd Measurement
Baseline (BL)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Male - - - - - - 958 958
Female - - - - - - 558 558
Gender vs AM Diastolic Blood Presure 2nd Measurement
Clinical Evaluation (CE)
N Mean StdDev Median Min Max Unknown Total
Total 1,504 73.4 ± 21.1 78.0 -2.0 138.0 12 1,516
Male 950 74.0 ± 22.0 78.0 -2.0 138.0 8 958
Female 554 72.4 ± 19.4 76.0 -2.0 120.0 4 558
Gender vs AM Diastolic Blood Presure 2nd Measurement
Diagnostic Visit (DX)
N Mean StdDev Median Min Max Unknown Total
Total 1,232 77.6 ± 13.9 78.0 -3.0 120.0 284 1,516
Male 788 78.4 ± 14.3 80.0 -3.0 120.0 170 958
Female 444 76.1 ± 13.1 76.0 -1.0 114.0 114 558
Gender vs AM Diastolic Blood Presure 2nd Measurement
CPAP Titration Visit (CPAP)
N Mean StdDev Median Min Max Unknown Total
Total 1,056 75.2 ± 18.6 78.0 -3.0 130.0 460 1,516
Male 693 76.2 ± 18.2 80.0 -3.0 130.0 265 958
Female 363 73.3 ± 19.2 78.0 -3.0 120.0 195 558
Gender vs AM Diastolic Blood Presure 2nd Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
N Mean StdDev Median Min Max Unknown Total
Total 879 76.3 ± 12.7 78.0 -2.0 122.0 637 1,516
Male 572 77.3 ± 12.4 78.0 -2.0 122.0 386 958
Female 307 74.4 ± 12.9 76.0 -1.0 110.0 251 558
Gender vs AM Diastolic Blood Presure 2nd Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
N Mean StdDev Median Min Max Unknown Total
Total 833 63.3 ± 30.2 74.0 -2.0 110.0 683 1,516
Male 541 64.6 ± 30.2 74.0 -2.0 110.0 417 958
Female 292 60.9 ± 30.3 70.0 -2.0 110.0 266 558
Gender vs AM Diastolic Blood Presure 2nd Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
N Mean StdDev Median Min Max Unknown Total
Total 851 76.5 ± 12.5 78.0 -2.0 118.0 665 1,516
Male 552 77.7 ± 12.1 78.0 -1.0 118.0 406 958
Female 299 74.2 ± 12.8 76.0 -2.0 98.0 259 558
Race/Ethnicity vs AM Diastolic Blood Presure 2nd Measurement
Baseline (BL)
N Mean StdDev Median Min Max Unknown Total
Total - - - - - - 1,516 1,516
Native American - - - - - - 28 28
Asian - - - - - - 89 89
Black - - - - - - 172 172
Hispanic - - - - - - 116 116
White - - - - - - 1,102 1,102
Other - - - - - - 9 9
Race/Ethnicity vs AM Diastolic Blood Presure 2nd Measurement
Clinical Evaluation (CE)
N Mean StdDev Median Min Max Unknown Total
Total 1,504 73.4 ± 21.1 78.0 -2.0 138.0 12 1,516
Native American 27 74.2 ± 19.2 74.0 -2.0 110.0 1 28
Asian 88 72.8 ± 17.1 75.5 -1.0 100.0 1 89
Black 170 73.2 ± 26.0 78.0 -1.0 138.0 2 172
Hispanic 114 76.1 ± 18.0 80.0 -1.0 110.0 2 116
White 1,096 73.2 ± 20.8 78.0 -2.0 138.0 6 1,102
Other 9 72.3 ± 29.3 78.0 -1.0 100.0 - 9
Race/Ethnicity vs AM Diastolic Blood Presure 2nd Measurement
Diagnostic Visit (DX)
N Mean StdDev Median Min Max Unknown Total
Total 1,232 77.6 ± 13.9 78.0 -3.0 120.0 284 1,516
Native American 20 79.0 ± 14.5 79.0 60.0 120.0 8 28
Asian 74 73.0 ± 15.8 75.5 -1.0 92.0 15 89
Black 120 78.7 ± 18.4 80.0 -2.0 116.0 52 172
Hispanic 84 78.1 ± 12.5 80.0 -1.0 102.0 32 116
White 926 77.7 ± 13.2 78.0 -3.0 116.0 176 1,102
Other 8 82.1 ± 7.3 81.0 74.0 94.0 1 9
Race/Ethnicity vs AM Diastolic Blood Presure 2nd Measurement
CPAP Titration Visit (CPAP)
N Mean StdDev Median Min Max Unknown Total
Total 1,056 75.2 ± 18.6 78.0 -3.0 130.0 460 1,516
Native American 16 80.1 ± 27.2 81.0 -1.0 130.0 12 28
Asian 58 75.7 ± 10.0 76.0 58.0 110.0 31 89
Black 96 74.7 ± 25.1 80.0 -1.0 122.0 76 172
Hispanic 73 78.3 ± 13.2 80.0 -1.0 112.0 43 116
White 808 74.8 ± 18.4 78.0 -3.0 110.0 294 1,102
Other 5 87.4 ± 10.2 90.0 72.0 100.0 4 9
Race/Ethnicity vs AM Diastolic Blood Presure 2nd Measurement
Two Month Post-CPAP Neurocognitive Visit (2M)
N Mean StdDev Median Min Max Unknown Total
Total 879 76.3 ± 12.7 78.0 -2.0 122.0 637 1,516
Native American 13 82.9 ± 14.7 82.0 62.0 110.0 15 28
Asian 49 74.1 ± 10.2 72.0 58.0 110.0 40 89
Black 77 79.8 ± 16.8 80.0 -1.0 122.0 95 172
Hispanic 65 76.1 ± 12.7 76.0 -1.0 102.0 51 116
White 672 75.9 ± 12.1 77.0 -2.0 108.0 430 1,102
Other 3 87.3 ± 7.0 88.0 80.0 94.0 6 9
Race/Ethnicity vs AM Diastolic Blood Presure 2nd Measurement
Four Month Post-CPAP Neurocognitive Visit (4M)
N Mean StdDev Median Min Max Unknown Total
Total 833 63.3 ± 30.2 74.0 -2.0 110.0 683 1,516
Native American 10 67.2 ± 25.7 73.0 -2.0 90.0 18 28
Asian 47 63.4 ± 26.6 72.0 -2.0 94.0 42 89
Black 73 63.9 ± 32.2 78.0 -2.0 98.0 99 172
Hispanic 57 68.4 ± 24.1 72.0 -2.0 106.0 59 116
White 643 62.6 ± 30.8 74.0 -2.0 110.0 459 1,102
Other 3 88.7 ± 11.0 88.0 78.0 100.0 6 9
Race/Ethnicity vs AM Diastolic Blood Presure 2nd Measurement
Six Month Post-CPAP Neurocognitive Visit (6M)
N Mean StdDev Median Min Max Unknown Total
Total 851 76.5 ± 12.5 78.0 -2.0 118.0 665 1,516
Native American 13 81.7 ± 11.3 80.0 68.0 112.0 15 28
Asian 50 74.5 ± 9.2 77.0 58.0 96.0 39 89
Black 75 82.8 ± 9.8 82.0 62.0 118.0 97 172
Hispanic 61 76.1 ± 13.0 76.0 -1.0 94.0 55 116
White 649 75.8 ± 12.8 78.0 -2.0 112.0 453 1,102
Other 3 85.3 ± 2.3 84.0 84.0 88.0 6 9